Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00870441 · ClinicalTrials.gov registry record · Phase 1
Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers
A Phase 1 study, sponsored by Astellas Pharma.
- Terminated
- Registry status
- Phase 1
- Development phase
- 442
- Enrollment target
NCT00870441 is a Phase 1 study that was terminated before completion, run by Astellas Pharma. The registered enrollment target is 442 participants.
The verdict
NCT00870441, a Phase 1 study, was terminated before completion, sponsored by Astellas Pharma.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 442 participants
- Enrollment target
Study Summary
The objective of the study is to compare the safety of ASP2151 to valacyclovir and placebo in healthy male and female adult volunteers.
Interventions
- DRUG Placebo
- DRUG Valacyclovir
- DRUG ASP2151
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 442 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00870441
The ClinicalTrials.gov registry entry for NCT00870441 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 442 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00870441 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00870441 about?
NCT00870441 is a clinical study titled "Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers". The objective of the study is to compare the safety of ASP2151 to valacyclovir and placebo in healthy male and female adult volunteers.
What is the current status of trial NCT00870441?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 442 participants. The study started on 2009-03. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00870441?
The interventions under investigation include: Placebo (DRUG), Valacyclovir (DRUG), ASP2151 (DRUG).
Who is sponsoring clinical trial NCT00870441?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.